Order Article Reprints

Wu L, Lin L, Yu M, Li H, Dang Y, Liang H, Chen G, Muhetaer H, Zheng G, Li J, et al. Antitumor Activity of USP7 Inhibitor GNE-6776 in Non-Small Cell Lung Cancer Involves Regulation of Epithelial-Mesenchymal Transition, Cell Cycle, Wnt/β-Catenin, and PI3K/AKT/mTOR Pathways. Pharmaceuticals. 2025; 18(2):245. https://doi.org/10.3390/ph18020245

Wu, Lipeng, Long Lin, Meng Yu, Huajian Li, Yuanye Dang, Huosheng Liang, Guangyang Chen, Halimulati Muhetaer, Guodong Zheng, Jingjing Li, and et al. 2025. "Antitumor Activity of USP7 Inhibitor GNE-6776 in Non-Small Cell Lung Cancer Involves Regulation of Epithelial-Mesenchymal Transition, Cell Cycle, Wnt/β-Catenin, and PI3K/AKT/mTOR Pathways" Pharmaceuticals 18, no. 2: 245. https://doi.org/10.3390/ph18020245

Wu, L., Lin, L., Yu, M., Li, H., Dang, Y., Liang, H., Chen, G., Muhetaer, H., Zheng, G., Li, J., Jia, X., Wu, B., & Li, C. (2025). Antitumor Activity of USP7 Inhibitor GNE-6776 in Non-Small Cell Lung Cancer Involves Regulation of Epithelial-Mesenchymal Transition, Cell Cycle, Wnt/β-Catenin, and PI3K/AKT/mTOR Pathways. Pharmaceuticals, 18(2), 245. https://doi.org/10.3390/ph18020245